#ESMO21 Expert Video Report on HER2-positive metastatic breast cancer

#ESMO21 Expert Video Report on immunotherapy in gastro-oesophageal cancerПодробнее

ASCO 2023 Expert Report in HR positive, HER2 negative breast cancer by Catherine Harper-WynneПодробнее

Expert report on tackling resistance to CDK4/6 inhibitors in ER+/HER2-metastatic breast cancerПодробнее

Expert Report on advances in the management of HER2-negative and HER2-low advanced breast cancerПодробнее

#ESMO21 Expert Video Report on Prostate cancerПодробнее

#ESMO21 Expert Video Report on HER2-positive early breast cancerПодробнее

#ESMO21 Expert Video Report on novelties in metastatic NSCLCПодробнее

#ESMO21 Expert Video Report on targeting in HER2-positive metastatic breast and lung cancersПодробнее

ESMO 2020 Expert Video Report on CDK4 6i in the adjuvant treatment of breast cancerПодробнее

PerELISA: overexpression of 13 genes associated with endocrine sensitivity in HR+/HER2+ BCПодробнее

DESTINY Breast 03 from #ESMO21 presenter Dr. Erika HamiltonПодробнее

DESTINY-04: HER2 1+/FISH- Metastatic Breast Cancer TDXD Treatment | Jane Meisel, MD | ASCO22 UpdatesПодробнее

Breast cancer research at ESMO 2021Подробнее

PD8 Spotlight Session 8 HER2 Positive Breast CancerПодробнее

HER2 Positive Breast Cancer: Everything You Must KnowПодробнее

HER2-positive breast cancer explanation videoПодробнее

Expert Commentary: Melanoma, Breast and Gynaecological Cancers at ESMO Congress 2021Подробнее